UBS Group’s ESSA Pharma EPIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$20.4K Sell
12,021
-11,587
-49% -$19.7K ﹤0.01% 7112
2025
Q1
$37.3K Sell
23,608
-72,006
-75% -$114K ﹤0.01% 6505
2024
Q4
$171K Buy
95,614
+93,197
+3,856% +$167K ﹤0.01% 5351
2024
Q3
$14.6K Buy
2,417
+852
+54% +$5.16K ﹤0.01% 6327
2024
Q2
$8.23K Sell
1,565
-2,061
-57% -$10.8K ﹤0.01% 6653
2024
Q1
$30.8K Sell
3,626
-1,269
-26% -$10.8K ﹤0.01% 5557
2023
Q4
$32.3K Buy
4,895
+4,730
+2,867% +$31.2K ﹤0.01% 5601
2023
Q3
$510 Sell
165
-265
-62% -$819 ﹤0.01% 7303
2023
Q2
$1.16K Sell
430
-2,824
-87% -$7.63K ﹤0.01% 6915
2023
Q1
$9.66K Sell
3,254
-3,268
-50% -$9.71K ﹤0.01% 6540
2022
Q4
$16.4K Buy
+6,522
New +$16.4K ﹤0.01% 6722
2022
Q3
Sell
-28,551
Closed -$90K 9325
2022
Q2
$90K Sell
28,551
-2,891
-9% -$9.11K ﹤0.01% 4512
2022
Q1
$194K Buy
31,442
+329
+1% +$2.03K ﹤0.01% 4409
2021
Q4
$442K Buy
31,113
+16,227
+109% +$231K ﹤0.01% 4073
2021
Q3
$119K Sell
14,886
-43,154
-74% -$345K ﹤0.01% 4636
2021
Q2
$1.66M Buy
58,040
+57,172
+6,587% +$1.63M ﹤0.01% 2876
2021
Q1
$25K Buy
868
+464
+115% +$13.4K ﹤0.01% 6150
2020
Q4
$5K Sell
404
-2,347
-85% -$29K ﹤0.01% 6795
2020
Q3
$19K Buy
+2,751
New +$19K ﹤0.01% 5472
2020
Q2
Sell
-1,625
Closed -$7K 7114
2020
Q1
$7K Buy
1,625
+913
+128% +$3.93K ﹤0.01% 6217
2019
Q4
$4K Buy
+712
New +$4K ﹤0.01% 6575
2018
Q2
Sell
-1,590
Closed -$6K 7049
2018
Q1
$6K Buy
1,590
+1,177
+285% +$4.44K ﹤0.01% 6247
2017
Q4
$2K Buy
+413
New +$2K ﹤0.01% 6622
2017
Q3
Sell
-300
Closed -$3K 6799
2017
Q2
$3K Buy
+300
New +$3K ﹤0.01% 6332
2016
Q1
Sell
-52
Closed -$4K 6734
2015
Q4
$4K Buy
+52
New +$4K ﹤0.01% 6383